These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 14684360

  • 1. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C.
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H83-90. PubMed ID: 14684360
    [Abstract] [Full Text] [Related]

  • 2. Cardioprotective effects of carvedilol on acute autoimmune myocarditis.
    Yuan Z, Shioji K, Nimata M, Kishimoto C.
    Mol Cell Biochem; 2004 Apr; 259(1-2):223-7. PubMed ID: 15124928
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
    Yue-Chun L, Li-Sha G, Jiang-Hua R, Peng-Lin Y, Jia-Feng L, Ji-Fei T, Peng C, Zhan-Qiu Y.
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):92-8. PubMed ID: 18209574
    [Abstract] [Full Text] [Related]

  • 4. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
    Feuerstein G, Liu GL, Yue TL, Cheng HY, Hieble JP, Arch JR, Ruffolo RR, Ma XL.
    Eur J Pharmacol; 1998 Jun 26; 351(3):341-50. PubMed ID: 9721026
    [Abstract] [Full Text] [Related]

  • 5. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
    Yaoita H, Sakabe A, Maehara K, Maruyama Y.
    Circulation; 2002 Feb 26; 105(8):975-80. PubMed ID: 11864928
    [Abstract] [Full Text] [Related]

  • 6. Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
    Li YC, Ge LS, Yang PL, Tang JF, Lin JF, Chen P, Guan XQ.
    Eur J Pharmacol; 2010 Aug 25; 640(1-3):112-6. PubMed ID: 20457150
    [Abstract] [Full Text] [Related]

  • 7. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
    Nishio R, Shioi T, Sasayama S, Matsumori A.
    J Am Coll Cardiol; 2003 Jan 15; 41(2):340-5. PubMed ID: 12535832
    [Abstract] [Full Text] [Related]

  • 8. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
    Pauschinger M, Rutschow S, Chandrasekharan K, Westermann D, Weitz A, Peter Schwimmbeck L, Zeichhardt H, Poller W, Noutsias M, Li J, Schultheiss HP, Tschope C.
    Eur J Heart Fail; 2005 Jun 15; 7(4):444-52. PubMed ID: 15921778
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol Inhibits Matrix Metalloproteinase-2 Activation in Experimental Autoimmune Myocarditis: Possibilities of Cardioprotective Application.
    Skrzypiec-Spring M, Haczkiewicz K, Sapa A, Piasecki T, Kwiatkowska J, Ceremuga I, Wozniak M, Biczysko W, Kobierzycki C, Dziegiel P, Podhorska-Okolow M, Szelag A.
    J Cardiovasc Pharmacol Ther; 2018 Jan 15; 23(1):89-97. PubMed ID: 28854816
    [Abstract] [Full Text] [Related]

  • 10. A comparison of carvedilol and metoprolol antioxidant activities in vitro.
    Lysko PG, Webb CL, Gu JL, Ohlstein EH, Ruffolo RR, Yue TL.
    J Cardiovasc Pharmacol; 2000 Aug 15; 36(2):277-81. PubMed ID: 10942172
    [Abstract] [Full Text] [Related]

  • 11. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun 15; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 12. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575
    [Abstract] [Full Text] [Related]

  • 13. Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis.
    Liu H, Li W, Gu W, Kong Y, Yang N, Chen L.
    Scand J Immunol; 2010 Jan 28; 71(1):38-44. PubMed ID: 20017808
    [Abstract] [Full Text] [Related]

  • 14. The mechanism of carvedilol in experimental viral myocarditis.
    Yue-Chun L, Li-Sha G, Xue-Qiang G, Jia-Feng L.
    Curr Pharm Des; 2012 Jan 28; 18(12):1620-4. PubMed ID: 22443630
    [Abstract] [Full Text] [Related]

  • 15. MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats.
    Nimata M, Okabe TA, Hattori M, Yuan Z, Shioji K, Kishimoto C.
    Am J Physiol Heart Circ Physiol; 2005 Dec 28; 289(6):H2514-8. PubMed ID: 16100244
    [Abstract] [Full Text] [Related]

  • 16. Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
    Yue-Chun L, Teng Z, Na-Dan Z, Li-Sha G, Qin L, Xue-Qiang G, Jia-Feng L.
    PLoS One; 2012 Dec 28; 7(6):e39394. PubMed ID: 22761780
    [Abstract] [Full Text] [Related]

  • 17. Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.
    Yuan Z, Nimata M, Okabe TA, Shioji K, Hasegawa K, Kita T, Kishimoto C.
    Am J Physiol Heart Circ Physiol; 2005 Sep 28; 289(3):H1147-52. PubMed ID: 15879491
    [Abstract] [Full Text] [Related]

  • 18. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC, Nelson AH, Ohlstein EH, Willette RN, Sealey JE, Laragh JH, Campbell WG, Feuerstein GZ.
    J Pharmacol Exp Ther; 1996 Nov 28; 279(2):948-55. PubMed ID: 8930204
    [Abstract] [Full Text] [Related]

  • 19. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

  • 20. Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production.
    Shimada K, Hirano E, Kimura T, Fujita M, Kishimoto C.
    Exp Biol Med (Maywood); 2012 Sep 02; 237(9):1039-44. PubMed ID: 22946091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.